↓ Skip to main content

Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status

Overview of attention for article published in Frontiers in oncology, March 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
3 X users

Readers on

mendeley
13 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Establish of an Initial Platinum-Resistance Predictor in High-Grade Serous Ovarian Cancer Patients Regardless of Homologous Recombination Deficiency Status
Published in
Frontiers in oncology, March 2022
DOI 10.3389/fonc.2022.847085
Pubmed ID
Authors

Yongmei Li, Yufei Nie, Hongyan Guo, Hua Guo, Chunfang Ha, Yuan Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 13 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 13 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 8%
Other 1 8%
Student > Bachelor 1 8%
Student > Ph. D. Student 1 8%
Researcher 1 8%
Other 1 8%
Unknown 7 54%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 23%
Biochemistry, Genetics and Molecular Biology 2 15%
Unspecified 1 8%
Materials Science 1 8%
Unknown 6 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2022.
All research outputs
#14,925,951
of 25,392,582 outputs
Outputs from Frontiers in oncology
#4,148
of 22,436 outputs
Outputs of similar age
#206,782
of 460,453 outputs
Outputs of similar age from Frontiers in oncology
#258
of 1,522 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 460,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 54% of its contemporaries.
We're also able to compare this research output to 1,522 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.